Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G17DT in advanced metastatic colorectal adenocarcinoma
NCT02181465Phase 2Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Oct 1993
- Primary completion
- May 1994
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of G17DT immunogen in colorectal adenocarcinoma, sponsored by Cancer Advances, Inc.. Started Oct 1993; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT02181465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181465.